Abstract: Advancing age in humans is associated with a decline in function of physiological systems, as well as the onset and progression of many chronic diseases. An ongoing focus of basic aging research is to identify biomarkers that could be used to assess the severity of age-related diseases or that could also be modulated to treat them. Telomerase is an enzyme with mechanistic links to telomere length homeostasis and cell viability. Human telomerase is a ribonucleoprotein complex that consists of its catalytic subunit (hTERT) and ribonucleic acid template (hTERC). Telomerase adds de novo TTAGGG repeats to the ends of telomeres, which may prevent telomere shortening and subsequent dysfunction in certain cell compartments. Telomerase function within the cell represents a growing area of interest among biologists who study human aging, due to its potential use as a biomarker and therapeutic target for chronic disease. Here I review the basic biology of telomerase and the consequences of telomerase overexpression and deficiency in human cells and animal models. I discuss the putative role of telomerase in telomere-length homeostasis with advancing age in humans. Finally, I describe novel nontelomeric activities of telomerase related to cell viability and mitochondrial function.
Aging and chronic disease
The US population is aging, and the number of older adults is expected to increase in the coming decades. 1, 2 Between 1980 and 2008, the population of adults in the US over the age of 65 increased from 25.6 to 38.9 million, while life expectancy after the age of 65 increased from 16.4 to 18.6 years. 2 Importantly, the prevalence of chronic diseases like Alzheimer's disease, heart disease, stroke, and hypertension is reproducibly higher in older adults compared with younger adults. [1] [2] [3] [4] Thus, the anticipated increase in chronic-disease patients due to our aging population represents a major concern for the US healthcare system in the 21st century. Many chronic diseases share some common pathological phenotypes, such as chronic inflammation and oxidative stress, as well as atrophy of the affected tissues. [5] [6] [7] [8] However, the molecular mechanisms that underlie these dysfunctional phenotypes are not completely understood. A better understanding of these mechanisms will lead to the identification of novel biomarkers that are predictive of chronic disease as well as lifestyle and pharmacological interventions to treat or even reverse age-related diseases in humans.
chromosome ends from resembling double-stranded deoxyribonucleic acid (DNA) breaks and initiating the DNA break response. [11] [12] [13] [14] The DNA break response can induce apoptosis or cellular senescence through tumor suppressor protein 53 (P53)-mediated expression of cyclin-dependent kinase inhibitor 1A (P21). 13, 14 In vitro studies of human cells have clearly shown that disrupting telomere-binding proteins leads to telomere deprotection, P53 activation, and P53/P21-induced senescence. 13, 14 Several other studies have described a P53-mediated senescence-associated phenotype, characterized by increased production of pro-inflammatory mediators, such as tumor necrosis factor-alpha, interleukin 6, interleukin 8, and monocyte chemotactic protein 1. [15] [16] [17] [18] [19] Thus, telomere dysfunction could contribute to biological aging and chronic disease by inducing senescence 13, 14, 20 and subsequent inflammatory phenotype in somatic tissues. [15] [16] [17] [18] [19] Telomere shortening represents a potential mechanism by which telomere dysfunction could occur with advancing age. Due to the inability of the DNA replication machinery to copy the very distal ends of chromosomes, telomeres shorten with each cell cycle in most human tissues. 9, [20] [21] [22] [23] [24] Numerous in vitro studies have linked telomere shortening to senescence in human cells. 9, 20, 25 Telomere shortening can also result from exposure to genotoxic stressors like reactive oxygen species (ROS), 26 ultraviolet radiation, 26 and nucleasedependent degradation. 25, 27, 28 In human aging, oxidative stress occurs in many tissues from the accumulation of ROS, such as superoxide. 5, 8, 29 Thus, chronic oxidative stress may be a particularly important mechanism underlying age-related telomere shortening in humans. 26 In vivo, telomere shortening with advancing age that exceeds some critical telomere length might result in telomere dysfunction, which could lead to P53/P21-induced senescence, inflammation, and subsequent tissue dysfunction.
However, in certain tissues, telomere-length homeostasis is maintained over time by the enzyme telomerase. 30 First discovered by Elizabeth Blackburn in Tetrahymena, telomerase is a reverse transcriptase that adds de novo TTAGGG repeats to chromosome ends. 31 Human telomerase is a ribonucleoprotein complex that consists of multiple components, including the catalytic subunit (hTERT), a ribonucleic acid (RNA) template component (hTERC), and various binding partners, such as dyskerin (DKC), telomerase cajal body protein 1 (TCAB1) and ribonucleoproteins NOP10, NHP2, and GAR1 ( Figure 1 ). 30, 32 During the process of telomere elongation, hTERT uses hTERC as a template from which to extend telomeric repeats. The various binding partners perform functions related to the localization of telomerase to telomeres and stability of the telomerase complex during the telomere elongation process. TCAB1 helps recruit and stabilize hTERT to telomeres, 33 while DKC, NHP2, GAR1, and NOP10 all appear to stabilize hTERC. [34] [35] [36] [37] Together, hTERT and these associated factors can efficiently add telomeric repeats to chromosome ends to compensate for telomere attrition.
While telomerase is constitutively active in germ cells, stem cells, and some somatic cells like white blood cells (WBCs), [38] [39] [40] [41] [42] [43] [44] its expression and activity is negligible in most somatic tissues. 45, 46 High levels of telomerase expression and activity in somatic cells have been linked to neoplastic cell transformation in humans. [47] [48] [49] [50] [51] [52] [53] Thus, the role of telomerase in normal aging and chronic disease is unclear and represents a growing area of research.
In vitro telomerase activity in human cells
Concomitant with cell cycle dependent telomere shortening, telomerase activity has been shown to decline as human cells become senescent in culture. 54, 55 This has led investigators to speculate that declines in telomerase activity may be a mechanism behind age-related telomere shortening, and maintenance of telomerase activity may extend the proliferative potential of cells. 55 Indeed, telomerase overexpression results in immortalization of human fibroblasts in vitro. 56, 57 While the possibilities of extending tissue survival in vivo by overexpressing telomerase are intriguing, there is inherent risk in allowing cells to escape senescence, as this could lead to tumorigenesis. Elevated telomerase activity has been found in the early stages of lung, colon, prostate, and breast cancers. 47, 48, 53 Additionally, mutations in telomerase-related genes and dysregulation of telomerase activity are suspected to play a role in the tumorigenesis of several common cancers. [58] [59] [60] Thus, translating in vitro telomerase overexpression-dependent improvements in cell survival to increased tissue survival and lifespan in vivo in humans may be limited in its practicality.
In vivo telomerase activity in mice Mouse models of telomerase overexpression
Mouse models of telomerase overexpression have been generated and used to assess the effects of increased telomerase expression/activity on tissue survival and lifespan in mammals. One such model, recently reviewed by Geserick and Blasco, 61 overexpresses mouse (m)Tert under the control of the bovine keratin 5 (K5) gene promoter. 62 The K5 mice are viable, fertile, and exhibit enhanced wound repair compared with wild type (WT) animals.
62 K5 mice also exhibit higher rates of cell proliferation in response to mitogenic signals than WT controls, which is likely linked to the increased hyperplasia and neoplasia observed in a variety of tissues in K5 mice, as compared with WT controls.
61 K5 mice have lower survival rates than WT controls, possibly related to the higher rates of tumorigenesis. 61 However, individuals that survive past 75 weeks appear to have lower mortality and morbidity than WT counterparts. 63 Interestingly, there is no difference in telomere length between K5 mice and WT mice. 62 Another model of telomerase overexpression was recently described by Bernardes de Jesus et al. 64 The authors showed that mice treated with adeno-associated virus expressing mTert lived longer and exhibited improved function in a variety of physiological systems. 64 The animals displayed improved fitness, insulin sensitivity, bone density, and neuromuscular coordination compared with the control animals, and showed no signs of increased tumorigenesis. 64 This exciting study represents the most convincing evidence to date that gene therapy aimed at increasing telomerase expression or activity could be useful for blunting age-related tissue dysfunction without increasing cancer risk.
Mouse models of telomerase deficiency
While models of telomerase overexpression have shown that increasing telomerase activity in vivo could be used to extend healthy lifespan in mammals, mouse models of telomerase deficiency have helped clarify the roles that telomerase and telomere-length homeostasis may play in normal tissue development, tissue function, and disease. WT mice have relatively long telomeres, high telomerase activity, and limited age-related telomere shortening compared with humans. 61, 65 This diminishes the utility of aged WT mice as a model of telomere shortening and telomerase function in humans. However, researchers have developed several transgenic mouse models of telomerase deficiency to mimic telomere shortening with advancing age in humans as well as many diseases linked to telomere dysfunction. 38, 44, [66] [67] [68] [69] [70] [71] [72] Various models of mice deficient for the mTerc gene have been created that lack the catalytic subunit of telomerase. [66] [67] [68] Another common model of telomerase deficiency involves deletion of the mTerc gene, which removes the RNA template from the telomerase complex. 38, 44, [69] [70] [71] [72] Both versions of telomerase deficient mice develop similar phenotypes, including shortened telomeres, diminished tissue renewal in bone marrow, germ cells, and intestines, as well as impaired wound repair. 38, 44, [66] [67] [68] [69] [70] [71] [72] To erode sufficiently the large telomere length reserve of mice, these mouse models of telomerase deficiency require breeding animals for multiple generations to attain the aforementioned phenotypes. 38, 44, [66] [67] [68] [69] [70] [71] [72] While functional telomerase may not be essential for embryonic development in these mice, these phenotypes do occur at earlier time points in later generations of animals due to the inheritance of progressively shorter telomeres. 38, 44, 68, 70 Combined with observations that telomerase deficiency appears most detrimental to stem cell compartments, 38, 44, 70 this suggests that normal telomerase function may be most relevant for telomerelength homeostasis during early growth and development in mammals. 42, 73 During the growth and development of adult somatic tissues, cells are in a highly proliferative state, and the relatively high levels of telomerase activity may help cells counteract cell cycle-dependent telomere shortening. 73 Although these studies do suggest that stem cell-mediated repair of adult somatic tissues may be an important physiology process negatively affected by reduced telomerase activity, a clear role for localized telomerase dysregulation in reduced tissue survival with advancing age or chronic disease remains elusive.
Interestingly, the general phenotypes of mTert and mTerc knockout mice resemble the etiology of a collection of blood disorders in humans, known as bone marrow failure syndrome (BMFS). BMFS includes, among other disorders, dyskeratosis congenita (DC), aplastic anemia (AA), myelodyplastic syndrome (MDS), [74] [75] [76] and genetic screens have revealed that mutations in the human (h)TERT, hTERC, and DKC genes are linked to inherited forms of these disorders. [77] [78] [79] [80] These mutations are thought to lead to telomerase dysregulation and subsequent telomere dysfunction, which -in turnleads to depletion of stem cells and diminishes the repair and renewal capacity of somatic tissues. 81 These effects are most pronounced in highly proliferative somatic tissues submit your manuscript | www.dovepress.com
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like hematopoietic stem cells in the bone marrow and result in a wide range of phenotypes including, but not limited to, mucosal leukoplakia, nail dystrophy, abnormal skin pigmentation, gastrointestinal atrophy, and tumors, as well as hematopoietic malignancies. [74] [75] [76] 81 Both mTERT and mTERC knockout mice develop their aforementioned phenotypes in a manner that is largely dependent on hematopoietic stem cell depletion in the bone marrow. 38, 44, 70 Indeed, these mice may not be true models of normal human aging, but they have proved to be valuable tools for researchers interested in understanding the central role of telomerase in BMFS.
Telomerase activity and human aging Telomerase activity and telomere-length homeostasis in human aging As alluded to above, defining a role for telomerase in human aging has been difficult for researchers who study aging processes. An obvious issue with the hypothesis that telomerase preserves telomere-length homeostasis in adults is that telomere shortening occurs over time in most human somatic tissues. 9, 21, 25 Another piece of evidence that is difficult to reconcile is the observation that telomerase expression levels are virtually undetectable in most fully differentiated human cells. 46 Furthermore, animal and human studies have suggested that telomerase activity in adult mammals is only high enough to maintain telomere length homeostasis in germ and adult stem cell populations. 38, 42, 44, 70, 73 Within these cell compartments, telomerase may be important for preventing senescence by maintaining telomere-length integrity in highly proliferative cells, like spermatocytes or hematopoietic stem cells. 42, 44, 70, 73 Some studies have detected telomerase activity, as well as shown age-related declines, in WBCs from humans. 41, 43 As is the case with germ or stem cells, activated WBCs are highly proliferative compared with other somatic cells. 39 This may explain the need for relatively high telomerase activity to maintain telomere length homeostasis in this cell compartment during an immune response. 39, 41 Thus, age-related declines in telomerase activity may compromise stem cell-mediated tissue repair, germ cell viability, and immune cell function in humans.
Another possibility is that telomerase activity in humans is most important for telomere-length homeostasis during early growth and development of somatic tissues, but it has limited relevance for tissue function and survival in adulthood. 42, 73 This prospect is strongly suggested by the animal studies described above and by Iwama et al, who showed, concomitant with progressive age-related telomere shortening, sharp age-related declines in telomerase activity in human WBCs up to the second decade of life. 41 After around 20 years of age, WBC telomerase activity appears to level off and remains low or barely detectable through the ninth decade of life. 41 While telomerase may not play a major role in telomere-length homeostasis with advancing age, a growing body of work suggests that telomerase may have important nontelomeric activities related to apoptosis resistance, cell proliferation control, and mitochondrial function in human cells.
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Telomere-independent roles for telomerase activity in human aging Telomerase activity and cell proliferation/ apoptosis control in humans Several studies have suggested that telomerase can support cell proliferation in a variety of human cell types by regulating expression of mitogenic genes. [83] [84] [85] Induced expression of telomerase has been shown to increase cell proliferation rates 85 and lead to increased expression of fibroblast growth factor (FGF). 83 Furthermore, telomerase overexpression can maintain expression of keratinocyte growth factor and insulin-like growth factor in senescent human fibroblasts. 84 Concomitant with increased FGF increases, Jin et al showed that fetal human fibroblasts had an increased tendency toward transformation, suggesting an increased risk of tumorigenesis following ectopic telomerase expression. 83 Likewise, there is substantial evidence that telomerase confers apoptosis resistance in many different cell types. For example, hTERT overexpression has been shown to reduce apoptotic susceptibility in cardiomyocytes. 86 The hTERT induction also suppresses apoptosis in smooth muscle cells and endothelial cells, with no evidence of increased tumorigenesis. 87, 88 Mattson et al suggest that hTERT suppresses apoptosis at a critical mitochondria-dependent step in neuronal cells, 89 while Xi et al showed that expression of the dominant negative form of telomerase results in enhanced apoptosis in HeLa cells. 90 The latter effect was likely due to an increase in the release of cytochrome C from the mitochondria. 90 Collectively, the effects of telomerase on cell proliferation and apoptosis suggest mechanisms by which dysregulation of telomerase could be linked to human aging. Reduced ability of tissues to repair damage with advancing age could lead to tissue dysfunction and, ultimately, chronic disease. A major consideration to this interpretation of telomerase's role in aging is the inherent cancer risk with any antiaging therapy aimed at reducing apoptosis and increasing cell proliferation rates by modulating telomerase expression or activity. 
Telomerase activity and mitochondrial function in humans
Another telomere-independent function of telomerase that may have aging implications is the protection of mitochondria and mitochondrial DNA (mtDNA) from oxidative damage. 91 The mitochondrial theory of aging maintains that, over time, oxidative damage to mitochondria and mtDNA leads to increased ROS inside cells, which, in turn, leads to age-related cell and tissue dysfunction. [92] [93] [94] A vicious cycle is thought to occur whereby oxidatively damaged mitochondria generate and release more ROS, which further damages cell components, including the mitochondria, leading to even more ROS production. 92, 94 Thus, identifying endogenous mechanisms that protect cells and mitochondria from oxidative damage represents an ongoing goal of basic aging research, due to their inherent therapeutic potential.
A growing body of evidence supports a role for telomerase in mitochondrial homeostasis. Indeed, telomerase may perform crucial regulatory functions within mitochondria in human cells, as mitochondrial translocation of telomerase leads to improved mitochondrial function. 82, 91, [95] [96] [97] The improvement in function is likely mediated through mechanisms like reduced mitochondria-derived ROS, improved respiratory chain function, and increased mitochondrial membrane potential. 91 The specific mechanisms by which telomerase improves mitochondrial function are unclear, but it has been shown to physically interact with and protect mtDNA from ROS in several different cell types. 82, 91, 95 Telomerase has even been shown to facilitate mitochondrial transfer RNA processing. 96 The beneficial effects of telomerase on mitochondrial function are putative mechanisms by which telomerase can protect cells from oxidative damage, as well as another plausible mechanism by which telomerase might confer apoptosis resistance by mitigating mitochondriadependent apoptosis. With respect to aging, modulation of telomerase interactions with mitochondria or telomerase expression with advancing age could lead to mitochondria dysfunction and increased oxidative stress in human cells and tissues.
Telomerase activity and chronic disease
While the role that telomerase plays in the normal aging process is currently unclear, telomerase dysregulation has been implicated in the etiology of some chronic diseases. Cardiovascular diseases (CVDs) are currently the most deadly diseases of aging in the US, and most deaths from CVDs are attributable to diseases of the arteries. 4, 98 An important study by Liu et al revealed elevated telomerase activity in atherosclerotic arteries compared with nonatherosclerotic controls. 99 Likewise, Kroenke et al found that greater telomerase activity in WBCs was associated with greater CVD risk. 100 These results are interesting because, similar to observations made in studies of telomerase and cancer risk, they suggest a maladaptive influence of increased telomerase activity and expression in the context of aging. However, age-related reductions in telomere length and telomerase activity in microglial cells from humans and rats suggest that telomerase may even play a role in Alzheimer's and dementias. 101 Taken together, these studies indicate that while telomerase may not be particularly relevant to the normal aging process, there are clear implications for telomerase dysregulation in the pathogenesis of chronic diseases. Importantly, it appears that elevated telomerase activity may be detrimental in the context of aging and age-related disease, despite the predicted benefits to telomere-length homeostasis.
Techniques for assessing telomerase activity in aging research
In a laboratory setting, telomerase can be measured by a variety of methodologies. For the purposes of quantifying telomerase activity and expression in the context of clinical research, the most common techniques used include the telomeric repeat amplification protocol (TRAP) assay, 41 Western blotting or quantitative reverse transcription polymerase chain reaction (RT-PCR) for expression of telomerase and related proteins and messenger RNA, 46, 91, 102 respectively. These methods are largely sufficient for assessing overall telomerase function within a tissue of interest. Another technique that has been utilized involves performing chromatin immunoprecipitation (ChIP) to measure relative amounts of telomerase bound to telomeres. 103 This technique allows investigators to obtain a fairly accurate picture of the in vivo function of telomerase within a cell. Indeed, ChIPs may be more informative for telomerase function than the TRAP assay or simple measures of telomerase expression, as changes in the amount of telomerase bound to telomeres should reflect the overall regulation of telomerase in response to an experimental condition. 103, 104 The caveat with using ChIPs to measure telomerase dynamics in a clinical research setting, is that these assays are technically difficult, time consuming, and expensive. 104 Thus, using cheaper and more straightforward techniques, such as RT-PCR, may be a better option for some investigators. 
Conclusion
Telomere dysfunction is a potentially important mechanism underlying the aging phenotype in humans. Maintaining telomere-length homeostasis throughout an individual's life may improve tissue survival, ameliorate some chronic diseases, and even extend healthy lifespan. Thus, the dynamics of telomerase and telomere-binding proteins with advancing age have generated substantial interest among biologists who study basic aging processes, as they represent putative intervention targets to prevent or to reverse telomere dysfunction. However, the role of telomerase in normal telomere-length homeostasis and telomere dysfunction in humans remains uncertain, and interventions aimed at modulating telomerase expression and activity may not yet be feasible, due to the inherent cancer risk. An emerging body of research supports the hypothesis that telomerase has several important telomere independent activities within human cells, such as cell proliferation control, apoptosis resistance, and mitochondrial function (Figure 2 ). These nontelomeric functions of telomerase might ultimately comprise the more important roles for telomerase in cell and tissue dysfunction with advancing age. Thus, therapeutic interventions targeting nontelomeric pathways involving telomerase could be the safest way to manipulate telomerase activity to blunt or reverse age-related tissue dysfunction and chronic diseases in humans.
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